Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 24, 2025
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
GlobeNewswire
·
April 24, 2025
- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 - WALTHAM, Mass., April 24, 2025 (GLOBE …
Amwell® to participate in upcoming investor conferences
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences: On May 8, Mark …
Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
GlobeNewswire
·
April 24, 2025
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology Lead product AVC-S-101 is a TROP2-targeting booster being developed for non-small cell lung cancer and multiple …
SEED Therapeutics Reports Breakthroughs for Two Targeted Protein Degradation Projects at AACR Annual Meeting in Chicago
GlobeNewswire
·
April 24, 2025
Two PROTAC synergy using two E3 ligases for achieving levels of degradation of KRAS G12D not achieved with single PROTACs, will be presented by the lab of Luca Busino, PhD, from the University of Pennsylvania, on April 27th SEED’s first IND candidate …
Mitolyn Reviews 2025: Why This Non-Stimulant Best Weight Loss Supplement Is a Game-Changer for Fat Burn and Metabolism
GlobeNewswire
·
April 24, 2025
Tallmadge, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- As more health-conscious individuals seek safer, stimulant-free alternatives for weight management in 2025, natural supplements are becoming the gold standard. Crash diets, intense fitness programs, and …
CRB Appoints Ken Olson as Chief Financial Officer
GlobeNewswire
·
April 24, 2025
Kansas City, Missouri, April 24, 2025 (GLOBE NEWSWIRE) -- CRB, a leading global provider of sustainable engineering, architecture, construction and consulting solutions to the life sciences and food and beverage industries, today announced the appointment …
The Joint Corp. to Host Conference Call on Thursday, May 8th to Discuss First Quarter 2025 Results
GlobeNewswire
·
April 24, 2025
SCOTTSDALE, Ariz., April 24, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) a national operator, manager, and franchisor of chiropractic clinics, announced it will report its first quarter 2025 financial results on Thursday, May 8, 2025, after the …
Pasithea Therapeutics to Present Updated Data from Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients at the 2025 ASCO Annual Meeting
GlobeNewswire
·
April 24, 2025
MIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of …
EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting
GlobeNewswire
·
April 24, 2025
Focal One i expands HIFUsion® patient-specific imaging compatibility to include PSMA PET, ExactVu™ Micro-Ultrasound, along with AI-driven and intelligent algorithms including Unfold AI™ and OnQ™ Prostate Focal One i extends HIFUsion capabilities to …
Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 24, 2025
JUPITER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report first quarter 2025 financial results before the opening of the U.S. financial markets on Thursday, May 8, 2025. The …
Kymera Therapeutics to Unveil New Oral Immunology Program and Report First Quarter 2025 Financial Results on May 9, 2025
GlobeNewswire
·
April 24, 2025
Watertown, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that it …
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
GlobeNewswire
·
April 24, 2025
WHO WHAT WHERE WHEN WHY Nuwellis, Inc. Issuance of U.S. Patent No. 12,280,007. United States Patent and Trademark Office April 22, 2025 To protect a novel self-emptying fluid bag design that improves nursing workflow while maintaining system accuracy. …
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
GlobeNewswire
·
April 24, 2025
SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited …
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
GlobeNewswire
·
April 24, 2025
Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research …
Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership
GlobeNewswire
·
April 24, 2025
ATHENS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer, a leading craft brewery known for its innovative and high-quality beers and a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), is thrilled to partner with Orvis, the renowned …
BioNTech präsentiert auf der AACR-Jahrestagung 2025 klinische und präklinische Daten zu mRNA- und Immunonkologie-Fokus-Programmen
GlobeNewswire
·
April 24, 2025
MAINZ, Deutschland, 24. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der diesjährigen Jahrestagung der American Association for Cancer Research („AACR“), die vom 25. bis 30. April 2025 in Chicago, …
BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025
GlobeNewswire
·
April 24, 2025
MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA cancer immunotherapies, next-generation immunomodulators, and targeted …
Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting
GlobeNewswire
·
April 24, 2025
WAYNE, Pa., April 24, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the presentation of several clinical studies at the 2025 American Urological Association Annual Meeting, …
Best Oral Steroid for Strength in 2025: Top Steroids for Bodybuilding, Cutting, Muscle Growth & Raw Power (By Crazy Bulk)
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- The best oral steroids aren’t just about size — they’re about performance, power, and pushing your body beyond its current limits. Whether you're a powerlifter aiming for new PRs, a CrossFit athlete chasing …
RadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call
GlobeNewswire
·
April 24, 2025
LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it …